Nye og genopdagede medikamenter til behandling af tuberkulose

Research output: Contribution to journalJournal articlepeer-review

Documents

  • Fulltext

    Final published version, 179 KB, PDF document

Tuberculosis (TB) is still a major challenge for global health, but in recent years there have been several important developments in treatment options. Shorter treatment regimens for latent TB, based on conventional drugs, offer better adherence and fewer side effects, while new and repurposed antibiotics have opened the door to more effective, shorter and less side effect-heavy treatments for drug susceptible TB and multidrug-resistant/extensively drug resistant TB as well as atypical mycobacterioses. This review investigates how these shorter and predominantly oral treatments, in the future, are expected to be used in combination with individualized precision medicine.

Translated title of the contributionNew and rediscovered treatments for tuberculosis
Original languageDanish
Article numberV10210783
JournalUgeskrift for Laeger
Volume184
Issue number10
Number of pages6
ISSN0041-5782
Publication statusPublished - 2022

ID: 301455279